NCI | Technology Transfer

Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome

Read more about Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome

Patent Cooperation Treaty
PCT/US2021/057229
Filed on 2021-10-29

Chimeric Antigen Receptors Targeting B-cell Maturation Antigen

Read more about Chimeric Antigen Receptors Targeting B-cell Maturation Antigen

US Patent 12,180,484
Filed on 2022-05-16

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

Sweden
18720845.9
Filed on 2018-04-05

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

Poland
18720845.9
Filed on 2018-04-05

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

The Netherlands
18720845.9
Filed on 2018-04-05

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

Italy
18720845.9
Filed on 2018-04-05

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

United Kingdom
18720845.9
Filed on 2018-04-05

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

France
18720845.9
Filed on 2018-04-05

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

Spain
18720845.9
Filed on 2018-04-05

STAT3 INHIBITOR FORMULATION

Read more about STAT3 INHIBITOR FORMULATION

Germany
18720845.9
Filed on 2018-04-05

Subscribe to NCI